Alto Neuroscience, Inc. (ANRO)
24.56
+0.53
(+2.21%)
USD |
NYSE |
Oct 09, 11:52
Alto Neuroscience Total Assets (Quarterly) : 254.07M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 254.07M |
| March 31, 2026 | 276.26M |
| December 31, 2025 | 184.69M |
| September 30, 2025 | 147.01M |
| June 30, 2025 | 157.88M |
| March 31, 2025 | 171.92M |
| December 31, 2024 | 177.54M |
| September 30, 2024 | 191.61M |
| Date | Value |
|---|---|
| June 30, 2024 | 197.36M |
| March 31, 2024 | 209.92M |
| December 31, 2023 | 86.63M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 50.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.82M |
| Shareholders Equity (Quarterly) | 219.25M |
| Debt to Equity Ratio | 0.1062 |
| Current Ratio | 14.85 |
| Net Debt Paydown Yield | 0.07% |